These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22094647)

  • 1. Pharmacotherapeutic implications of the association between genomic instability at chromosome 15q13.3 and autism spectrum disorders.
    Deutsch SI; Urbano MR; Burket JA; Herndon AL; Winebarger EE
    Clin Neuropharmacol; 2011; 34(6):203-5. PubMed ID: 22094647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic abnormalities in autism: is there a rationale for selective nicotinic agonist interventions?
    Deutsch SI; Urbano MR; Neumann SA; Burket JA; Katz E
    Clin Neuropharmacol; 2010 May; 33(3):114-20. PubMed ID: 20190638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Evolving Therapeutic Rationale for Targeting the α
    Deutsch SI; Burket JA
    Curr Top Behav Neurosci; 2020; 45():167-208. PubMed ID: 32468495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 15q13.3 deletion syndrome: Deficient α(7)-containing nicotinic acetylcholine receptor-mediated neurotransmission in the pathogenesis of neurodevelopmental disorders.
    Deutsch SI; Burket JA; Benson AD; Urbano MR
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():109-17. PubMed ID: 26257138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.
    Roncarati R; Scali C; Comery TA; Grauer SM; Aschmi S; Bothmann H; Jow B; Kowal D; Gianfriddo M; Kelley C; Zanelli U; Ghiron C; Haydar S; Dunlop J; Terstappen GC
    J Pharmacol Exp Ther; 2009 May; 329(2):459-68. PubMed ID: 19223665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7).
    Freedman R; Leonard S; Gault JM; Hopkins J; Cloninger CR; Kaufmann CA; Tsuang MT; Farone SV; Malaspina D; Svrakic DM; Sanders A; Gejman P
    Am J Med Genet; 2001 Jan; 105(1):20-2. PubMed ID: 11424985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated administration of alpha7 nicotinic acetylcholine receptor (nAChR) agonists, but not positive allosteric modulators, increases alpha7 nAChR levels in the brain.
    Christensen DZ; Mikkelsen JD; Hansen HH; Thomsen MS
    J Neurochem; 2010 Aug; 114(4):1205-16. PubMed ID: 20533993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of α7 nicotinic acetylcholine receptors in regulating tumor necrosis factor-α (TNF-α) as revealed by subtype selective agonists.
    Li J; Mathieu SL; Harris R; Ji J; Anderson DJ; Malysz J; Bunnelle WH; Waring JF; Marsh KC; Murtaza A; Olson LM; Gopalakrishnan M
    J Neuroimmunol; 2011 Oct; 239(1-2):37-43. PubMed ID: 21911260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First administration of cytidine diphosphocholine and galantamine in schizophrenia: a sustained alpha7 nicotinic agonist strategy.
    Deutsch SI; Schwartz BL; Schooler NR; Rosse RB; Mastropaolo J; Gaskins B
    Clin Neuropharmacol; 2008; 31(1):34-9. PubMed ID: 18303489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 3-Mb map of a large Segmental duplication overlapping the alpha7-nicotinic acetylcholine receptor gene (CHRNA7) at human 15q13-q14.
    Riley B; Williamson M; Collier D; Wilkie H; Makoff A
    Genomics; 2002 Feb; 79(2):197-209. PubMed ID: 11829490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease.
    Bitner RS; Bunnelle WH; Decker MW; Drescher KU; Kohlhaas KL; Markosyan S; Marsh KC; Nikkel AL; Browman K; Radek R; Anderson DJ; Buccafusco J; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):875-86. PubMed ID: 20504913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Consequences of CHRNA7 Copy-Number Alterations in Induced Pluripotent Stem Cells and Neural Progenitor Cells.
    Gillentine MA; Yin J; Bajic A; Zhang P; Cummock S; Kim JJ; Schaaf CP
    Am J Hum Genet; 2017 Dec; 101(6):874-887. PubMed ID: 29129316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
    Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization and high-throughput screening of positive allosteric modulators of α7 nicotinic acetylcholine receptors in IMR-32 neuroblastoma cells.
    Gopalakrishnan SM; Philip BM; Gronlien JH; Malysz J; Anderson DJ; Gopalakrishnan M; Warrior U; Burns DJ
    Assay Drug Dev Technol; 2011 Dec; 9(6):635-45. PubMed ID: 21309712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.
    Olincy A; Harris JG; Johnson LL; Pender V; Kongs S; Allensworth D; Ellis J; Zerbe GO; Leonard S; Stevens KE; Stevens JO; Martin L; Adler LE; Soti F; Kem WR; Freedman R
    Arch Gen Psychiatry; 2006 Jun; 63(6):630-8. PubMed ID: 16754836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of alpha7-nicotinic acetylcholine receptors in tetanic stimulation-induced gamma oscillations in rat hippocampal slices.
    Song C; Murray TA; Kimura R; Wakui M; Ellsworth K; Javedan SP; Marxer-Miller S; Lukas RJ; Wu J
    Neuropharmacology; 2005 May; 48(6):869-80. PubMed ID: 15829257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological, pharmacological, and molecular evidence for alpha7-nicotinic acetylcholine receptors in rat midbrain dopamine neurons.
    Wu J; George AA; Schroeder KM; Xu L; Marxer-Miller S; Lucero L; Lukas RJ
    J Pharmacol Exp Ther; 2004 Oct; 311(1):80-91. PubMed ID: 15178698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors.
    Prickaerts J; van Goethem NP; Chesworth R; Shapiro G; Boess FG; Methfessel C; Reneerkens OA; Flood DG; Hilt D; Gawryl M; Bertrand S; Bertrand D; König G
    Neuropharmacology; 2012 Feb; 62(2):1099-110. PubMed ID: 22085888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha7 nAChR-mediated activation of MAP kinase pathways in PC12 cells.
    Gubbins EJ; Gopalakrishnan M; Li J
    Brain Res; 2010 Apr; 1328():1-11. PubMed ID: 20211606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of alpha7-nicotinic receptor subunit and alpha7-like gene expression in the prefrontal cortex of patients with bipolar disorder and schizophrenia.
    De Luca V; Likhodi O; Van Tol HH; Kennedy JL; Wong AH
    Acta Psychiatr Scand; 2006 Sep; 114(3):211-5. PubMed ID: 16889592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.